Pfizer to buy 8.1 percent stake in French vaccines company Valneva

📆 2022/06/20 22:30:00
📰 Reuters

⏱ Reading Time:
13 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 97%

日本ニュースニュース

日本最新ニュース,日本見出し

U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake in French vaccines company , as the companies announced developments in their partnership to tackle the Lyme disease.

Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of 9.49 euros per share, via a reserved capital increase.Register now for FREE unlimited access to Reuters.comValneva will use the proceeds from Pfizer’s equity investment to support its Phase 3 development contribution to the Lyme disease program.

"Pfizer's investment in Valneva highlights the quality of the work that we’ve done together over the past two years and is a strong recognition of Valneva's vaccine expertise," said Valneva chief executive Thomas Lingelbach.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。続きを読む:

コメントを書く

Get some more jabs in you. The 8th or 9th booster will work

日本 最新ニュース, 日本 見出し

日本最新ニュース, 日本見出し